Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06027073 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biologics and Sublingual Immunotherapy

Study acronym: BSIPL
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 7, 2023 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Most current studies involve using a biological drug to increase the safety of allergen immunotherapy (AIT) especially in the treatment of food allergies, to avoid the risk of anaphylaxis. However, adding Xolair® to AIT may improve the therapy's effectiveness. There are still few observations on this topic, especially in patients with house dust mite (HDM)-driven asthma.
Trial Details
NCT Number NCT06027073
Lead Sponsor Medical University of Silesia
Collaborators: Centrum Medyczne Andrzej Bożek
Conditions
(from sponsor)		 Asthma, Allergic
Related terms Asthma
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov